Device company ZOLL® Medical Corporation, tells us it has reached a definitive agreement to acquire Advanced Circulatory Systems, Inc., which develops technologies to non-invasively increase circulation.
ZOLL Medical Corporation describes itself as a developer and marketer of medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. These include defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, therapeutic temperature management, and ventilation.
Advanced Circulatory Systems’ innovative technologies use the body’s own mechanisms to enhance circulation without the use of pharmaceutical or other agents. The company’s novel Intrathoracic Pressure Regulation (IPR) therapy platform is a non-invasive therapy that can potentially protect the heart, brain, and other vital organs when blood flow is compromised, giving rescuers, clinicians, and caregivers the potential to return patients to a full life after critical medical emergencies.
Multiple studies have demonstrated how Advanced Circulatory Systems’ technologies may assist in increasing circulation, cardiac output, and systolic blood pressure.
ZOLL anticipates the transaction will close in early 2015.
Advanced Circulatory Systems will continue to operate out of Minnesota as a part of ZOLL’s Core Products division.
“The acquisition of Advanced Circulatory Systems will broaden ZOLL’s product offerings with additional technologies designed to improve outcomes from cardiac arrest and other critical conditions,” said Jonathan A. Rennert, President of ZOLL. “This acquisition further demonstrates ZOLL’s commitment to offering the most comprehensive portfolio of products for acute events where rapid medical intervention is needed.”
for Advanced Circulatory Systems
“Becoming part of ZOLL provides Advanced Circulatory Systems with an increased infrastructure of clinical and commercial resources that will enable our technologies to reach a greater number of clinicians and positively affect more patients’ lives,” said Mike Black, CEO of Advanced Circulatory Systems. “The acquisition gives Advanced Circulatory Systems the opportunity to become a part of a company with a long history of improving resuscitation science.”
Source: Zoll Medical Corporation, Business Wire